Richard Eaton to retire as MITA’s director of industry programs

Evan Godt | | Health Imaging | Artificial Intelligence

Richard Eaton, currently serving as the director of industry programs for the Medical Imaging and Technology Alliance (MITA), will retire next month after 26 years with the National Electrical Manufacturers Association (NEMA) and MITA.

Eaton joined NEMA as an industry manager in 1988. Since then, his teams have written standards in ultrasound, nuclear medicine, IT and more. He also helped coordinate a number of large-scale research projects, including the extracorporeal lithotripter clinical trial.

“Rich’s dry sense of humor, his positive attitude and his expertise will be sorely missed,” said Gail Rodriquez, PhD, executive director of MITA.

Eaton’s retirement will be effective April 15.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.